Project Grant HT94252410894
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$750K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
The Defense Health Agency awarded a $2,475,390.00 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2024 to August 31, 2028, will fund a multifaceted intervention titled "MULTIFACETED INTERVENTION TO RESTORE RESILIENCE AND OVERCOME RISK (MIRROR)." As a renowned academic medical center, ISMMS will leverage its expertise in areas such as...
The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
The U.S. Department of Defense's Defense Health Agency awarded a $2,385,311 Project Grant (CFDA 12.420 - Military Medical Research and Development) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant will fund a 4-year study to evaluate the efficacy of a criteria-based clinical pathway for rehabilitation of shoulder injuries. The project involves technical expertise from sub-awardees the University of Southern California and The Geneva Foundation. Key...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
The Department of the Army Medical Command has awarded a $3,300,817 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York. This federal grant, with a performance period from June 1, 2025 to May 31, 2029, supports advanced biomedical research focused on leveraging personalized stem cell therapy to overcome airway reconstruction challenges. ISMMS, a prominent academic medical center and federal...
The federal Project Grant award of $437,420.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support advanced biomedical research by the Icahn School of Medicine at Mount Sinai (ISMMS) to transform healthcare for military service members and the broader public. The research aims to leverage personalized stem cell therapy to overcome airway reconstruction challenges. The award was granted on June 1, 2025 with an...
The Defense Health Agency awarded The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, a $1,986,275 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of biofabricated, patient-specific skin gloves as a personalized therapy for mitten deformities in epidermolysis bullosa, a rare genetic skin disorder. The project will run from June 15, 2023 to June 14, 2027. The Military...
The Icahn School of Medicine at Mount Sinai will receive $760,500 from the Defense Health Agency under a three-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to functionally identify high-dimensional driver combinations in basal-like breast cancer. Through February 1, 2023 to January 31, 2026, this award will support the Icahn School of Medicine's efforts to transform health care for service members and the...
The Icahn School of Medicine at Mount Sinai will receive $1,521,002 under a three-year Project Grant award from the Defense Health Agency. The grant will support research from August 1, 2023 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). Specifically, the funding will enable research to determine the contribution of lineage intermediate tumor cells during progression to T-SCNC. This work aligns with the Military Medical Research and Development...
The Icahn School of Medicine at Mount Sinai has been awarded a $591,486 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, running from September 1, 2023 to August 31, 2026, will support the development of a novel immuno-oncology pipeline for FGFR2 fusion-positive cholangiocarcinoma. The funding will enable the medical school to conduct research aimed at transforming health care for service members and the...